Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser

References

1. Athan E., Chu V. H., Tattevin P., Selton-Suty C., Jones P., Naber C., Miró J. M., Ninot S., Fernández-Hidalgo N. other authors 2012; Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices. JAMA 307:1727–1735 [View Article][PubMed]
   [Google Scholar]
2. Bacak V., Biocina B., Starcevic B., Gertler S., Begovac J. 2006; Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient–case report and review of literature. J Infect 53:e11–e14 [View Article][PubMed]
   [Google Scholar]
3. Baddley J. W., Benjamin D. K. Jr, Patel M., Miró J., Athan E., Barsic B., Bouza E., Clara L., Elliott T. other authors 2008; Candida infective endocarditis. Eur J Clin Microbiol Infect Dis 27:519–529 [View Article][PubMed]
   [Google Scholar]
4. Barrau K., Boulamery A., Imbert G., Casalta J. P., Habib G., Messana T., Bonnet J. L., Rubinstein E., Raoult D. 2004; Causative organisms of infective endocarditis according to host status. Clin Microbiol Infect 10:302–308 [View Article][PubMed]
   [Google Scholar]
5. Daas H., Abuhmaid F., Zervos M. 2009; Successful treatment of Candida parapsilosis and Pseudomonas aeruginosa infection using medical and surgical management in an injecting drug user with mitral and aortic valve endocarditis: a case report. J Med Case Reports 3:6598 [View Article][PubMed]
   [Google Scholar]
6. Jain D., Oberoi J. K., Shahi S. K., Shivnani G., Wattal C. 2011; Scopulariopsis brevicaulis infection of prosthetic valve resembling aspergilloma on histopathology. Cardiovasc Pathol 20:381–383 [View Article][PubMed]
   [Google Scholar]
7. Jiang C., Dong D., Yu B., Cai G., Wang X., Ji Y., Peng Y. 2013; Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China. J Antimicrob Chemother 68:778–785 [View Article][PubMed]
   [Google Scholar]
8. Kumar P., Muranjan M. N., Tullu M. S., Vaideeswar P., Kher A., Lahiri K. R. 2010; Candida tropicalis endocarditis: Treatment in a resource-poor setting. Ann Pediatr Cardiol 3:174–177 [View Article][PubMed]
   [Google Scholar]
9. Melamed R., Leibovitz E., Abramson O., Levitas A., Zucker N., Gorodisher R. 2000; Successful non-surgical treatment of Candida tropicalis endocarditis with liposomal amphotericin-B (AmBisome). Scand J Infect Dis 32:86–89 [View Article][PubMed]
   [Google Scholar]
10. Millar B. C., Moore J. E. 2004; Current trends in the molecular diagnosis of infective endocarditis. Eur J Clin Microbiol Infect Dis 23:353–365 [View Article][PubMed]
    [Google Scholar]
11. Millar B. C., Moore J. E., Mallon P., Xu J., Crowe M., Mcclurg R., Raoult D., Earle J., Hone R., Murphy P. 2001; Molecular diagnosis of infective endocarditis–a new Duke’s criterion. Scand J Infect Dis 33:673–680 [View Article][PubMed]
    [Google Scholar]
12. Millar B. C., Jugo J., Moore J. E. 2005; Fungal endocarditis in neonates and children. Pediatr Cardiol 26:517–536 [View Article][PubMed]
    [Google Scholar]
13. Moreillon P., Que Y. A. 2004; Infective endocarditis. Lancet 363:139–149 [View Article][PubMed]
    [Google Scholar]
14. Nadir E., Rubinstein E. 2004; Fungal endocarditis. Curr Infect Dis Rep 6:276–282 [View Article][PubMed]
    [Google Scholar]
15. Nahass R. G., Weinstein M. P., Bartels J., Gocke D. J. 1990; Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients. J Infect Dis 162:967–970 [View Article][PubMed]
    [Google Scholar]
16. Oz Y., Kiremitci A., Dag I., Metintas S., Kiraz N. 2013; Postantifungal effect of the combination of caspofungin with voriconazole and amphotericin B against clinical Candida krusei isolates. Med Mycol 51:60–65 [View Article][PubMed]
    [Google Scholar]
17. Pierrotti L. C., Baddour L. M. 2002; Fungal endocarditis, 1995-2000. Chest 122:302–310 [View Article][PubMed]
    [Google Scholar]
18. Prendergast B. D. 2006; The changing face of infective endocarditis. Heart 92:879–885 [View Article][PubMed]
    [Google Scholar]
19. Rajendram R., Alp N. J., Mitchell A. R., Bowler I. C., Forfar J. C. 2005; Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement. Clin Infect Dis 40:e72–e74 [View Article][PubMed]
    [Google Scholar]
20. Saito Y., Takahashi M., Sato A., Katsuki T., Ikeda U., Shimada K. 2001; Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation. Intern Med 40:403–404 [View Article][PubMed]
    [Google Scholar]
21. Sousa C., Botelho C., Rodrigues D., Azeredo J., Oliveira R. 2012; Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis 31:2905–2910 [View Article][PubMed]
    [Google Scholar]
22. Talarmin J. P., Boutoille D., Tattevin P., Abgueguen P., Ansart S., Roblot F., Raffi F. 2009; Candida endocarditis: role of new antifungal agents. Mycoses 52:60–66 [View Article][PubMed]
    [Google Scholar]
23. Wang’ondu R. W., Murray T. S. 2011; Relapse of polymicrobial endocarditis in an intravenous drug user. Yale J Biol Med 84:321–324[PubMed]
    [Google Scholar]
24. White T. J., Bruns T., Lee S., Taylor J. 1990; Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In PCR Protocols: a Guide to Methods and Applications pp. 315–322 Edited by Innis M. A., Gelfand D. H., Sninsky J. J., White T. J. New York: Academic Press;
    [Google Scholar]